Short answer · Medically reviewed summary · Last updated: 2026-05-08
Adult T-cell leukemia/lymphoma (ATL) is a rare, aggressive malignancy of mature T-lymphocytes caused by the human T-cell lymphotropic virus type 1 (HTLV-1). It is primarily known by its official medical abbreviation, ATL, though it may occasionally be referred to by historical terms such as "Adult T-cell leukemia" or "HTLV-1-associated lymphoma" in older clinical literature. What are the common synonyms and historical names for ATL? While Adult T-cell leukemia/lymphoma is the standardized term, patients may encounter various descriptors in their medical records.
Adult T-cell leukemia/lymphoma ATL synonyms
Other names for Adult T-cell leukemia/lymphoma ATL: synonyms, acronyms and related terms used by doctors and patients.
Adult T-cell leukemia/lymphoma (ATL) is a rare, aggressive malignancy of mature T-lymphocytes caused by the human T-cell lymphotropic virus type 1 (HTLV-1). It is primarily known by its official medical abbreviation, ATL, though it may occasionally be referred to by historical terms such as "Adult T-cell leukemia" or "HTLV-1-associated lymphoma" in older clinical literature.
What are the common synonyms and historical names for ATL?
While Adult T-cell leukemia/lymphoma is the standardized term, patients may encounter various descriptors in their medical records. Historically, as researchers worked to define the relationship between the virus and the malignancy, the condition was sometimes documented as "Adult T-cell leukemia" (ATL) or "HTLV-1-associated T-cell lymphoma." In some international contexts, particularly in regions where the virus is endemic, it may be categorized based on its clinical manifestation, such as "smoldering," "chronic," "lymphoma," or "acute" Adult T-cell leukemia/lymphoma.
How is Adult T-cell leukemia/lymphoma classified officially?
Medical professionals and researchers rely on standardized classification systems to ensure consistent diagnosis and treatment. The most common identifiers include:
- ICD-10/11: Classified under codes related to mature T-cell and NK-cell neoplasms (e.g., C91.5).
- Orphanet: Listed under ORPHA:238583.
- OMIM: Documented under #613044.
- WHO Classification: The World Health Organization officially recognizes the condition as Adult T-cell leukemia/lymphoma, emphasizing its distinct molecular and clinical profile.
Why does this condition have multiple names?
The nomenclature for Adult T-cell leukemia/lymphoma has evolved alongside our understanding of the HTLV-1 retrovirus. Early reports focused on the leukemia-like presentation, while later research confirmed the lymphomatous characteristics of the disease. This dual nature is why Adult T-cell leukemia/lymphoma is the globally preferred term today; it acknowledges that the disease can manifest as a circulating leukemia, a nodal lymphoma, or both simultaneously.
Next steps
- Consult with a hematologist-oncologist specializing in peripheral T-cell lymphomas.
- Request a copy of your pathology report to confirm the specific sub-type of Adult T-cell leukemia/lymphoma.
- Connect with the 2 community members on DiseaseMaps.org who are navigating this diagnosis.
- Review clinical trial databases for emerging therapies specifically targeting HTLV-1-associated malignancies.
Medical disclaimer: This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment; always seek the advice of your physician regarding a medical condition.
References
- Orphanet: Adult T-cell leukemia/lymphoma (ORPHA:238583)
- NIH GARD: Adult T-cell leukemia/lymphoma
- OMIM: Adult T-cell leukemia/lymphoma (#613044)
- World Health Organization (WHO) Classification of Tumours of Haematopoietic and Lymphoid Tissues
